Morning Overview on MSN
Revolution Medicines trial points to longer survival in pancreatic cancer
For more than two decades, oncologists treating advanced pancreatic cancer have watched new drugs fail to move the survival ...
CStone Pharmaceuticals ('CStone,' HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key ...
Even if you wear sunscreen daily, one key symptom could make the difference between early detection and a life-threatening ...
Revolution Medicine has wowed investors and analysts by announcing dazzling data from its Phase III RASolute 302 trial ...
The specific mix of bacteria living in a person's gut can predict the chances that melanoma will recur after surgery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results